R&D of Core Medical and Dental Products and Foundational Technologies

「MANI developed this product to improve the safety and comfort of tooth extraction procedures as it works to address these medical challenges.」

「Under Medium-Term Management Plan 2029, we have identified the fundamental strengthening of our research and development capabilities and the launch of next-generation core products as one of our key objectives. Beginning with the fiscal year ending August 2026, we will also launch a new product development project and begin developing products that could become our next core products.」

「During the consolidated fiscal year, the company improved the quality of ophthalmic knives, developed an automated mass-production line for ophthalmic knives for smart factories, and improved vitreous forceps.」

「Beginning in September 2024, we launched JIZAI Pre 020, a new product in the JIZAI¹ series of NiTi rotary files for dental root canal treatment, designated as a priority development product under the medium-term management plan.」

「During the consolidated fiscal year, the company improved the quality of ophthalmic knives, developed an automated mass-production line for ophthalmic knives for smart factories, and improved and expanded the lineup of vitreous forceps.」

「The Group conducts research and development into new products in each field and technologies for improving existing products. It also works on common research themes, including intellectual property management, such as patents, and research and validation of automated production lines.」

「In addition, we completed the regulatory registration and obtained regulatory approval for the Vitreous Forceps, which we had been developing as a priority product under the medium-term management plan. We also established a mass-production structure for the NiTi rotary file and are conducting marketing activities, including seminars to raise awareness, to expand sales.」

「In addition, we established a mass-production structure for the NiTi rotary file, a priority product under the medium-term management plan, and advanced development of the new Vitreous Forceps for launch in the second half of the fiscal year.」

「Over the medium to long term, the company will incorporate input from overseas physicians, rather than relying solely on domestic physicians, through the activities of its sales offices and advance the development of new products reflecting global needs.」

「The company established a new system for carefully selecting themes, with the goal of further applying a “select and concentrate” approach to development themes, and worked to shorten development times by effectively concentrating resources on high-priority themes. It also shared marketing information with its German base, GDF Gesellschaft für dentale Forschung und Innovationen GmbH, and promoted the development of new dental restorative materials.」

「The company established a structure aimed at efficient and effective development by carefully selecting promising development themes and concentrating resources on the highest-priority themes. It also continued to strengthen its structure for new product development and research to improve existing products in order to achieve and maintain “world-leading quality” through technical exchanges and shared use of equipment across segment boundaries.」

「In its new product development structure, the company sought to promote technical exchanges among developers by having the development planning function thoroughly manage the core technologies cultivated in each segment. It also worked to establish a structure for carefully selecting development themes expected to generate future profits and allocating resources to them in a focused and effective manner.」

「In its new product development structure, the company also strengthened the development planning function and promoted technical exchanges by bringing together the core technologies cultivated in each segment.」

「The company consolidated the development functions of the Surgical, Atraumatic Needles, and Dental segments and brought together the core technologies cultivated in each segment to promote technical exchanges. It advanced a research and development structure for new products and improvements to existing products to efficiently and robustly achieve and maintain “world-leading quality.”」

「In development, beginning in the previous fiscal year, we consolidated the development functions for the Surgical, Eyeless Needle and Dental segments, and, in addition to cross-segment technical exchange and shared equipment, shifted to a project-based structure that enables agile development management, thereby further accelerating new product development.」

「In development, the company consolidated the development functions of the Surgical, Atraumatic Needles, and Dental segments to further invigorate development activities. It promoted cross-segment technical exchanges and shared use of equipment, while focusing on new product development and research to improve existing products.」

「The company is conducting research and development on products that will form the core of its future business in medical surgery and dental treatment, as well as on basic technologies that will serve as the seeds for such products. At the same time, it is conducting research and development on technologies for improving existing products, production technologies and management technologies.」

「In development, the company continues to conduct production technology development and research into improvements to existing products in cooperation with its overseas sites to achieve and maintain world-class quality, while focusing on new-product development to expand sales in developed markets.」

「To achieve and maintain world-class quality, the company has conducted production technology development and research into improvements to existing products in cooperation with its overseas sites, while focusing on new-product development to expand sales in developed markets.」

「The company is conducting research and development on products that will form the core of its future business in medical surgery and dental treatment, as well as on basic technologies that will serve as the seeds for such products. At the same time, it is conducting research and development on technologies for improving existing products, production technologies and management technologies.」